142 related articles for article (PubMed ID: 11389101)
1. Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets.
Reubi JC; Gugger M; Waser B; Schaer JC
Cancer Res; 2001 Jun; 61(11):4636-41. PubMed ID: 11389101
[TBL] [Abstract][Full Text] [Related]
2. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line.
Amlal H; Faroqui S; Balasubramaniam A; Sheriff S
Cancer Res; 2006 Apr; 66(7):3706-14. PubMed ID: 16585197
[TBL] [Abstract][Full Text] [Related]
3. Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting.
Reubi C; Gugger M; Waser B
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):855-62. PubMed ID: 12111125
[TBL] [Abstract][Full Text] [Related]
4. High expression of neuropeptide Y1 receptors in ewing sarcoma tumors.
Körner M; Waser B; Reubi JC
Clin Cancer Res; 2008 Aug; 14(16):5043-9. PubMed ID: 18698022
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.
Sheriff S; Ali M; Yahya A; Haider KH; Balasubramaniam A; Amlal H
Mol Cancer Res; 2010 Apr; 8(4):604-14. PubMed ID: 20332211
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors.
Körner M; Reubi JC
J Neuropathol Exp Neurol; 2008 Aug; 67(8):741-9. PubMed ID: 18648328
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
8. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).
Reubi JC; Wenger S; Schmuckli-Maurer J; Schaer JC; Gugger M
Clin Cancer Res; 2002 Apr; 8(4):1139-46. PubMed ID: 11948125
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y stimulates DNA synthesis in human vascular smooth muscle cells through neuropeptide Y Y1 receptors.
Nilsson T; Edvinsson L
Can J Physiol Pharmacol; 2000 Mar; 78(3):256-9. PubMed ID: 10721818
[TBL] [Abstract][Full Text] [Related]
10. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
11. NPY receptors in human cancer: a review of current knowledge.
Körner M; Reubi JC
Peptides; 2007 Feb; 28(2):419-25. PubMed ID: 17223228
[TBL] [Abstract][Full Text] [Related]
12. High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia.
Körner M; Waser B; Reubi JC
Clin Cancer Res; 2004 Dec; 10(24):8426-33. PubMed ID: 15623622
[TBL] [Abstract][Full Text] [Related]
13. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing.
Ekstrand AJ; Cao R; Bjorndahl M; Nystrom S; Jonsson-Rylander AC; Hassani H; Hallberg B; Nordlander M; Cao Y
Proc Natl Acad Sci U S A; 2003 May; 100(10):6033-8. PubMed ID: 12730369
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats.
Silva AP; Xapelli S; Pinheiro PS; Ferreira R; Lourenço J; Cristóvão A; Grouzmann E; Cavadas C; Oliveira CR; Malva JO
J Neurochem; 2005 Apr; 93(1):163-70. PubMed ID: 15773916
[TBL] [Abstract][Full Text] [Related]
15. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
16. Role of neuropeptide Y and its receptors in the progression of endocrine-related cancer.
Ruscica M; Dozio E; Motta M; Magni P
Peptides; 2007 Feb; 28(2):426-34. PubMed ID: 17204352
[TBL] [Abstract][Full Text] [Related]
17. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
18. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
[TBL] [Abstract][Full Text] [Related]
19. Unaltered neuropeptide Y (NPY)-stimulated [35S]GTPgammaS binding suggests a net increase in NPY signalling after repeated electroconvulsive seizures in mice.
Christensen DZ; Olesen MV; Kristiansen H; Mikkelsen JD; Woldbye DP
J Neurosci Res; 2006 Nov; 84(6):1282-91. PubMed ID: 16941487
[TBL] [Abstract][Full Text] [Related]
20. Expression of the HER family mRNA in breast cancer tissue and association with cell cycle inhibitors p21(waf1) and p27(kip1).
Kalemi TG; Papazisis KT; Lambropoulos AF; Voyatzi S; Kotsis A; Kortsaris AH
Anticancer Res; 2007; 27(2):913-20. PubMed ID: 17465220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]